- Company/Commercial (24)
- Corporate (15)
- Banking / Finance (14)
- Litigation / Dispute Resolution (10)
- Energy (7)
- Employment (6)
- Financial services (6)
- Funds (6)
- Commodities (5)
- Competition/EU (5)
- Intellectual Property (5)
- Crime (3)
- Environment (3)
- Information Technology (3)
- Pharma/Biotech (3)
- Real Estate (3)
- Tax (3)
- Telecoms (3)
- Insurance/reinsurance (2)
- Media/Entertainment/Sport (2)
- Pensions (2)
- Agriculture (1)
- Human Rights (1)
- Insolvency & restructuring (1)
- Planning (1)
- Private Equity (1)
Sort By: Newest first | Oldest first
Companies in the federal supply chain have an opportunity to prepare for the expansion of government’s anti-human-trafficking rules
This update highlights the salient aspects of the proposed rules and the requirements that are likely to be of most interest to contractors.
Companies should assess their business operations and relationships in Ukraine.
Mark Jones and David Moss of Hogan Lovells have commented following the publication of Sir Ian Wood’s ‘UKCS Maximising Recovery’ report.
FDA revises forms for submission of patent information to the Orange Book: Federal Circuit decision alters patent term adjustment
Two recent developments will affect the listing of patent information with pharmaceutical products approved by the US Food and Drug Administration.
Hogan Lovells’ head of planning, Michael Gallimore, has commented on the government’s further amendments to the Community Infrastructure Levy Regulations.
A section in last year’s Enterprise and Regulatory Reform Act is coming into force for claims started on or after 6 April.
Hogan Lovells has advised Kuwait Petroleum International on the Italian Shell acquisition.
Federal judge limits antitrust scrutiny of pharmaceutical reverse payments to settlements involving monetary transfers
A judge held that only patent settlements involving a reverse monetary payment will be subject to antitrust scrutiny under the framework articulated by the Supreme Court last year in FTC v Actavis.
NYSE and NASDAQ post forms for listed companies to certify compliance with revised compensation committee listing standards
Companies listed on the NYSE and NASDAQ are required to certify their compliance with some of the revised standards.
The LSE has published AIM Notice 38, which announced its consultation on proposed changes to the AIM Rules for Companies and the AIM Rules for Nominated Advisers.
A US federal judge declared on 8 January 2014 that Bazaarvoice violated Section 7 of the Clayton Act by acquiring its main rival, Powerreviews.
A number of Hogan Lovells partners have been listed as All-Stars in the 2014 BTI Client Services All-Star report.
Hogan Lovells has announced that Rachel Brandenburger is joining its antitrust, competition and economic regulation (ACER) practice as a senior adviser.
This may be the year that swap market counterparties face the full effect of dual US and foreign regulatory requirements for cross-border swap activities.
Hogan Lovells’ bribery and corruption task force expects increased enforcement against executives and enforcement co-operation between countries.
Elizabeth Slattery, partner in Hogan Lovells’ employment team, has commented on the TUPE reforms.
Hogan Lovells reviews the latest developments in the area of anti-bribery and corruption regulation and enforcement around the world.
On 30 November 2013, the State Council of China issued the Guiding Opinions on the Pilot Launch of Preference Shares.
This bi-annual China TMT report analyses some of the key developments in the TMT sector over the past few months.
Hogan Lovells has outlined the impact of this development on US companies and on foreign companies that are not ultimately owned or controlled by US persons/entities.